---
title: "Portage Biotech Reports Decreased Quarterly Loss"
description: "Portage Biotech Inc. reported a decreased net loss of $2.7 million for the fiscal quarter ended June 30, 2024, down from $4.2 million last year, primarily due to reduced research and development costs"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/212668766.md"
published_at: "2024-08-27T12:59:56.000Z"
---

# Portage Biotech Reports Decreased Quarterly Loss

> Portage Biotech Inc. reported a decreased net loss of $2.7 million for the fiscal quarter ended June 30, 2024, down from $4.2 million last year, primarily due to reduced research and development costs from paused clinical trials. The company is exploring strategic alternatives to boost shareholder value, which may include partnerships or mergers, while continuing to advance its immuno-oncology portfolio.

Portage Biotech Inc (**PRTG**) has released an update.

Portage Biotech Inc. has reported a significant decrease in net loss for the fiscal quarter ended June 30, 2024, with a reduction from $4.2 million to $1.7 million compared to the same period last year, reflecting lower research and development costs due to paused clinical trials. The company is actively seeking strategic alternatives to enhance shareholder value, which may include partnerships, sales, mergers, or finanical restructuring. Despite discontinuing certain program trials, Portage remains committed to advancing its immuno-oncology portfolio and clinical collaborations to improve cancer patient outcomes.

For further insights into PRTG stock, check out TipRanks’ Stock Analysis page.

### Related Stocks

- [PRTG.US - Portage Biotech](https://longbridge.com/en/quote/PRTG.US.md)
- [ATON.US - AlphaTON Capital](https://longbridge.com/en/quote/ATON.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| AlphaTON Capital 和 Compedica 解除股份交換協議 | AlphaTON Capital Corp. 和 Compedica Holdings Limited 已終止於 2025 年 6 月 5 日簽署的股份交換協議。新的協議於 2026 年 2 月 6 日簽署，撤銷了該交易，兩家公司將歸還所交 | [Link](https://longbridge.com/en/news/275510234.md) |
| AlphaTON Capital 在香港共識大會上展示了其機密的 AI 基礎設施 | AlphaTON Capital Corp.（納斯達克代碼：ATON）將在 2026 年 2 月 11 日至 12 日的香港共識大會上展示其去中心化的人工智能基礎設施。此次活動將包括關鍵會議，討論數字金融轉型和人工智能中的隱私問題。活動結束 | [Link](https://longbridge.com/en/news/275591389.md) |
| BioPorto A/S 任命 Klaus Juhl Wulff 為首席財務官 | BioPorto A/S 已任命 Klaus Juhl Wulff 為新的執行副總裁兼首席財務官，任職時間最遲從 2026 年 5 月 1 日開始。Wulff 在財務、運營、併購和資本市場方面擁有超過 20 年的經驗，曾擔任 AquaPor | [Link](https://longbridge.com/en/news/275277303.md) |
| AlphaTON 的 Claude Connector 加速了用户從竊取創意和數據的大型科技公司 AI 實踐中轉移的趨勢 | AlphaTON Capital Corp. 已推出 AlphaTON Claude Connector，這是一個通過 Telegram 將 Anthropic 的 Claude AI 與 TON 區塊鏈連接的平台。該工具允許用户使用自然語 | [Link](https://longbridge.com/en/news/274319291.md) |
| AlphaTON Capital Corp.發佈了中期財務報表的修正案 | AlphaTON Capital Corp. 已修訂截至 2025 年和 2024 年 9 月 30 日的三個月和六個月的中期財務報表。更新後的報表於 2026 年 1 月 12 日編制，包含有關近期私募融資和公司資本管理方法變更的詳細信息 | [Link](https://longbridge.com/en/news/273220565.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.